Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Enlivex Ltd. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q1 2021
- Shares held
- 987.8K
- −71.8K (−6.8%) vs. Q1 2021
- Total value
- $8.79M
- −$2.94M (−25.1%) vs. Q1 2021
- New holders
- 4
- 5 more added
- Sold out
- 7
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 514,807 | $4.58M | 0.01% | +38,393+8.1% | Added |
| Renaissance Technologies LLC | 195,706 | $1.74M | 0.00% | −94,700−32.6% | Reduced |
| ACT Capital Management, LLC | 82,500 | $735.0K | 0.38% | +82,500 | New |
| Golden Green, Inc. | 46,020 | $410.0K | 0.31% | −23,762−34.1% | Reduced |
| Compagnie Lombard Odier SCmA | 25,000 | $220.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 21,493 | $191.0K | 0.00% | −26,613−55.3% | Reduced |
| Wells Fargo & Company | 19,491 | $174.0K | 0.00% | +1,500+8.3% | Added |
| Steward Partners Investment Advisory, LLC | 15,500 | $136.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14,102 | $126.0K | 0.00% | −1,429−9.2% | Reduced |
| UBS Group AG | 13,420 | $120.0K | 0.00% | +2,548+23.4% | Added |
| Edmond de Rothschild Holding S.A. | 13,000 | $116.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,524 | $94.0K | 0.00% | −546−4.9% | Reduced |
| Banque Cantonale Vaudoise | 10,000 | $89.0K | 0.00% | +10,000 | New |
| Advisor Group Holdings, Inc. | 2,500 | $22.0K | 0.00% | +200+8.7% | Added |
| Captrust Financial Advisors | 1,025 | $9.00K | 0.00% | +25+2.5% | Added |
| Bank of America Corp | 897 | $8.00K | 0.00% | −2,238−71.4% | Reduced |
| Advisory Services Network, LLC | 950 | $8.00K | 0.00% | +950 | New |
| Citigroup Inc | 500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 249 | $2.22K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 130 | $1.00K | 0.00% | +130 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −33,889−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,986−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,285−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,489−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| SOA Wealth Advisors, LLC. | 0 | $0 | 0.00% | −327−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −125−100.0% | Sold out |